FDA Device recall Z-1947-2015
Etest Cefotaxime CT 256 WW and Etest Cefotaxime CT 256 US. in vitro diagnostic
- FDA Device
- Class II
- terminated
- Published 2015-07-08
On 2015-07-08 the FDA classified a Class II recall of Etest Cefotaxime CT 256 WW and Etest Cefotaxime CT 256 US. in vitro diagnostic by Biomerieux, citing QC results were out of range resulting in false resistant strains.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-1947-2015 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2015-06-12 |
| Published | 2015-07-08 |
| Last updated | 2026-09-13 11:53 UTC |
| Company | Biomerieux |
| Distribution | US |
Product
Etest Cefotaxime CT 256 WW and Etest Cefotaxime CT 256 US. in vitro diagnostic.
Reason
QC results were out of range resulting in false resistant strains.
Identifiers
| code_info | 1002774320, 1002377890, 1002590470, 1002775330, 1002379610 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:53 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1947-2015%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.